ROVI.MC vs. LONN.SW
Compare and contrast key facts about Laboratorios Farmaceuticos ROVI (ROVI.MC) and Lonza Group AG (LONN.SW).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ROVI.MC or LONN.SW.
Performance
ROVI.MC vs. LONN.SW - Performance Comparison
Returns By Period
In the year-to-date period, ROVI.MC achieves a 4.41% return, which is significantly lower than LONN.SW's 44.67% return. Over the past 10 years, ROVI.MC has outperformed LONN.SW with an annualized return of 22.26%, while LONN.SW has yielded a comparatively lower 18.85% annualized return.
ROVI.MC
4.41%
-18.27%
-28.41%
21.58%
21.34%
22.26%
LONN.SW
44.67%
-8.01%
-4.04%
44.14%
9.31%
18.85%
Fundamentals
| ROVI.MC | LONN.SW | |
|---|---|---|
| Market Cap | €3.34B | CHF 40.30B |
| EPS | €3.18 | CHF 7.97 |
| PE Ratio | 20.55 | 70.11 |
| Total Revenue (TTM) | €563.97M | CHF 6.70B |
| Gross Profit (TTM) | €334.55M | CHF 1.96B |
| EBITDA (TTM) | €143.29M | CHF 1.85B |
Key characteristics
| ROVI.MC | LONN.SW | |
|---|---|---|
| Sharpe Ratio | 0.64 | 1.50 |
| Sortino Ratio | 0.95 | 2.43 |
| Omega Ratio | 1.15 | 1.30 |
| Calmar Ratio | 0.62 | 0.77 |
| Martin Ratio | 1.88 | 6.62 |
| Ulcer Index | 10.36% | 6.77% |
| Daily Std Dev | 30.41% | 29.94% |
| Max Drawdown | -66.94% | -76.67% |
| Current Drawdown | -31.30% | -34.03% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between ROVI.MC and LONN.SW is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
ROVI.MC vs. LONN.SW - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Laboratorios Farmaceuticos ROVI (ROVI.MC) and Lonza Group AG (LONN.SW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ROVI.MC vs. LONN.SW - Dividend Comparison
ROVI.MC's dividend yield for the trailing twelve months is around 1.44%, more than LONN.SW's 0.79% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROVI.MC Laboratorios Farmaceuticos ROVI | 1.44% | 1.74% | 2.15% | 0.42% | 0.37% | 0.26% | 0.56% | 0.95% | 0.91% | 0.94% | 1.24% | 1.08% |
LONN.SW Lonza Group AG | 0.79% | 0.99% | 0.66% | 0.39% | 0.48% | 0.78% | 1.08% | 1.04% | 1.42% | 1.53% | 1.92% | 2.54% |
Drawdowns
ROVI.MC vs. LONN.SW - Drawdown Comparison
The maximum ROVI.MC drawdown since its inception was -66.94%, smaller than the maximum LONN.SW drawdown of -76.67%. Use the drawdown chart below to compare losses from any high point for ROVI.MC and LONN.SW. For additional features, visit the drawdowns tool.
Volatility
ROVI.MC vs. LONN.SW - Volatility Comparison
Laboratorios Farmaceuticos ROVI (ROVI.MC) has a higher volatility of 16.08% compared to Lonza Group AG (LONN.SW) at 10.35%. This indicates that ROVI.MC's price experiences larger fluctuations and is considered to be riskier than LONN.SW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ROVI.MC vs. LONN.SW - Financials Comparison
This section allows you to compare key financial metrics between Laboratorios Farmaceuticos ROVI and Lonza Group AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities